MOSCOW: Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, according to a statement on the Sputnik V Twitter account on Friday.Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021, the statement said.Phase II-III trials are ongoing in India, the statement said. Drugmaker Dr Reddy's Laboratories Ltd has said it expects late-stage trials to be completed by as early as March 2021.
Thursday, November 26, 2020
Russia agrees to produce Sputnik V in India | Economic Times
Subscribe to:
Post Comments (Atom)
-
HYDERABAD: The National Institute of Nutrition (NIN) has added another 5kg to the ideal weight of Indians. While the weight of an ideal or r...
-
Morgan Stanley and JPMorgan say buy the dip after treasury rout https://ift.tt/VBYjxPd Stanley sees scope for a rebound in Treasuries on exp...
-
Maruti an attractive bet on high margins, but slowing demand could be a worry https://ift.tt/VrpMTAI course, we aren't talking about its...
No comments:
Post a Comment